The findings highlight that EBV can control the biphasic life cycle by coordinating with host factors such as BRD7, ultimately providing insights into understanding the viral infection, pathogenesis, and BRD7-based therapeutics for EBV-associated BL. Here, BRD7 is linked to Burkitt lymphoma.